12/09/2024
8:03 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
7:39 AM | Lyell Immunopharma (Filer)
| Form 424B5 | |
12/05/2024
11:15 PM | Lyell Immunopharma (Filer)
| Form EFFECT | |
11/29/2024
3:19 PM | Lyell Immunopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/26/2024
3:05 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:30 PM | Lyell Immunopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:54 PM | Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
11/01/2024
3:56 PM | Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
5:00 PM | Foresite Capital Fund IV, L.P. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G | |
10/31/2024
3:45 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:06 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
7:32 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
3:41 PM | Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:03 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
7:06 AM | Lyell Immunopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
7:12 AM | Lyell Immunopharma (Filer)
| Form 424B5 | |
05/05/2024
11:15 PM | Lyell Immunopharma (Filer)
| Form EFFECT | |
04/22/2024
3:15 PM | Lyell Immunopharma (Filer)
| Form DEF 14A | |
04/22/2024
3:16 PM | Lyell Immunopharma (Filer)
| Form DEFA14A | |
04/22/2024
3:17 PM | Lyell Immunopharma (Filer)
| Form ARS | |
02/14/2024
2:18 PM | ARCH Venture Fund IX, L.P. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G/A | |
02/13/2024
7:22 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:24 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:25 PM | Lang Matthew (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:17 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:19 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G | |
